MindMatters | November 2021
In this edition, the gift of giving makes a true difference in the lives of patients, families and brain tumor scientists at the American Brain Tumor Association; read more about a humble ABTA National Conference speaker who shares his brain tumor journey; and a special meeting helps glue scientists to brain tumor research.
The ABTA creates a community that offers hope, support and reassurance that you’re not alone. As our community continues to grow, we know that with your help, there is so much more we can do. Learn how you can act now to help us provide imperative services that reach as many people as possible.
In his own words, Rick Franzo shares his brain tumor experience at the ABTA National Conference. Learn why Rick’s greatest takeaway from his journey is hope.
We look back at the past 10 ABTA Alumni Research Network (AARN) Annual Meetings with the first co-chair, Justin D. Lathia, PhD to see progress, new faces and emerging ideas to advance brain tumor science.
The ABTA surveyed patients, caregivers and physicians on the diagnosis and treatment of brain metastases and found disparities in care and communication. Published in the journey Neuro-Oncology Practice, this data highlight the needs of metastatic brain tumor patients.
When you think of being a newlywed, what comes to mind? Laughter, love, spending forever with your partner—these are just a few things Amanda thought of. Cancer never crossed her mind.
The 30-year-old internal medicine physician, author, and speaker shares the journey of her unexpected diagnosis and embracing the “Difficult Gifts” of a brain tumor at the 2021 ABTA National Conference, September 10-11.
Whether you walk, bike, rollerblade or push a stroller, anyone, anywhere can BT5K Your Way. Get inspired by three participants joining our nationwide event in creative and unique ways that celebrate their family, friends and loved ones impacted by a brain tumor diagnosis.
The American Brain Tumor Association (ABTA) persists in its mission, announcing today the investment of $368,000 towards 11 new research grants to foster innovation in diagnosis and treatment of brain tumors in adults and children.